769 related articles for article (PubMed ID: 33800000)
1. Potential Role of Curcumin and Its Nanoformulations to Treat Various Types of Cancers.
Kabir MT; Rahman MH; Akter R; Behl T; Kaushik D; Mittal V; Pandey P; Akhtar MF; Saleem A; Albadrani GM; Kamel M; Khalifa SAM; El-Seedi HR; Abdel-Daim MM
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33800000
[TBL] [Abstract][Full Text] [Related]
2. Targeted nanogel conjugate for improved stability and cellular permeability of curcumin: synthesis, pharmacokinetics, and tumor growth inhibition.
Wei X; Senanayake TH; Bohling A; Vinogradov SV
Mol Pharm; 2014 Sep; 11(9):3112-22. PubMed ID: 25072100
[TBL] [Abstract][Full Text] [Related]
3. Orthogonal self-assembly of an organoplatinum(II) metallacycle and cucurbit[8]uril that delivers curcumin to cancer cells.
Datta S; Misra SK; Saha ML; Lahiri N; Louie J; Pan D; Stang PJ
Proc Natl Acad Sci U S A; 2018 Aug; 115(32):8087-8092. PubMed ID: 30038010
[TBL] [Abstract][Full Text] [Related]
4. Curcumin mediates anticancer effects by modulating multiple cell signaling pathways.
Kunnumakkara AB; Bordoloi D; Harsha C; Banik K; Gupta SC; Aggarwal BB
Clin Sci (Lond); 2017 Aug; 131(15):1781-1799. PubMed ID: 28679846
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotective actions of curcumin on the pathogenic NFAT/COX-2/prostaglandin E
Hernández M; Wicz S; Corral RS
Phytomedicine; 2016 Nov; 23(12):1392-1400. PubMed ID: 27765359
[TBL] [Abstract][Full Text] [Related]
6. Advances in nanotechnology-based delivery systems for curcumin.
Sun M; Su X; Ding B; He X; Liu X; Yu A; Lou H; Zhai G
Nanomedicine (Lond); 2012 Jul; 7(7):1085-100. PubMed ID: 22846093
[TBL] [Abstract][Full Text] [Related]
7. Drug induced micellization into ultra-high capacity and stable curcumin nanoformulations: Physico-chemical characterization and evaluation in 2D and 3D in vitro models.
Lübtow MM; Nelke LC; Seifert J; Kühnemundt J; Sahay G; Dandekar G; Nietzer SL; Luxenhofer R
J Control Release; 2019 Jun; 303():162-180. PubMed ID: 30981815
[TBL] [Abstract][Full Text] [Related]
8. Curcumin-enhanced chemosensitivity of FDA-approved platinum (II)-based anti-cancer drugs involves downregulation of nuclear endonuclease G and NF-κB as well as induction of apoptosis and G2/M arrest.
Wang YT; Liu HS; Su CL
Int J Food Sci Nutr; 2014 May; 65(3):368-74. PubMed ID: 24438326
[TBL] [Abstract][Full Text] [Related]
9. Curcumin, an active component of turmeric in the prevention and treatment of ulcerative colitis: preclinical and clinical observations.
Baliga MS; Joseph N; Venkataranganna MV; Saxena A; Ponemone V; Fayad R
Food Funct; 2012 Nov; 3(11):1109-17. PubMed ID: 22833299
[TBL] [Abstract][Full Text] [Related]
10. Experimental and clinical reports on anti-inflammatory, antioxidant, and immunomodulatory effects of Curcuma longa and curcumin, an updated and comprehensive review.
Memarzia A; Khazdair MR; Behrouz S; Gholamnezhad Z; Jafarnezhad M; Saadat S; Boskabady MH
Biofactors; 2021 May; 47(3):311-350. PubMed ID: 33606322
[TBL] [Abstract][Full Text] [Related]
11. Curcumin in the treatment of liver cancer: From mechanisms of action to nanoformulations.
Shelash Al-Hawary SI; Abdalkareem Jasim S; M Kadhim M; Jaafar Saadoon S; Ahmad I; Romero Parra RM; Hasan Hammoodi S; Abulkassim R; M Hameed N; K Alkhafaje W; Mustafa YF; Javed Ansari M
Phytother Res; 2023 Apr; 37(4):1624-1639. PubMed ID: 36883769
[TBL] [Abstract][Full Text] [Related]
12. Curcumin: New Insights into an Ancient Ingredient against Cancer.
Willenbacher E; Khan SZ; Mujica SCA; Trapani D; Hussain S; Wolf D; Willenbacher W; Spizzo G; Seeber A
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013694
[TBL] [Abstract][Full Text] [Related]
13. Combined treatment of curcumin and small molecule inhibitors suppresses proliferation of A549 and H1299 human non-small-cell lung cancer cells.
Lin HP; Kuo LK; Chuu CP
Phytother Res; 2012 Jan; 26(1):122-6. PubMed ID: 21567511
[TBL] [Abstract][Full Text] [Related]
14. Liposomal curcumin and its application in cancer.
Feng T; Wei Y; Lee RJ; Zhao L
Int J Nanomedicine; 2017; 12():6027-6044. PubMed ID: 28860764
[TBL] [Abstract][Full Text] [Related]
15. Curcumin suppresses the TPA-induced invasion through inhibition of PKCα-dependent MMP-expression in MCF-7 human breast cancer cells.
Kim JM; Noh EM; Kwon KB; Kim JS; You YO; Hwang JK; Hwang BM; Kim BS; Lee SH; Lee SJ; Jung SH; Youn HJ; Lee YR
Phytomedicine; 2012 Sep; 19(12):1085-92. PubMed ID: 22921746
[TBL] [Abstract][Full Text] [Related]
16. A Review of Curcumin and Its Derivatives as Anticancer Agents.
Tomeh MA; Hadianamrei R; Zhao X
Int J Mol Sci; 2019 Feb; 20(5):. PubMed ID: 30818786
[TBL] [Abstract][Full Text] [Related]
17. Curcuma as an adjuvant in colorectal cancer treatment.
Villegas C; Perez R; Sterner O; González-Chavarría I; Paz C
Life Sci; 2021 Dec; 286():120043. PubMed ID: 34637800
[TBL] [Abstract][Full Text] [Related]
18. Intracellular Uptake of Curcumin-Loaded Solid Lipid Nanoparticles Exhibit Anti-Inflammatory Activities Superior to Those of Curcumin Through the NF-κB Signaling Pathway.
Wang J; Zhu R; Sun D; Sun X; Geng Z; Liu H; Wang SL
J Biomed Nanotechnol; 2015 Mar; 11(3):403-15. PubMed ID: 26307824
[TBL] [Abstract][Full Text] [Related]
19. Curcumin encapsulation in nanostructures for cancer therapy: A 10-year overview.
D'Angelo NA; Noronha MA; Kurnik IS; Câmara MCC; Vieira JM; Abrunhosa L; Martins JT; Alves TFR; Tundisi LL; Ataide JA; Costa JSR; Jozala AF; Nascimento LO; Mazzola PG; Chaud MV; Vicente AA; Lopes AM
Int J Pharm; 2021 Jul; 604():120534. PubMed ID: 33781887
[TBL] [Abstract][Full Text] [Related]
20. A combination index and glycoproteomics-based approach revealed synergistic anticancer effects of curcuminoids of turmeric against prostate cancer PC3 cells.
Wei MM; Zhao SJ; Dong XM; Wang YJ; Fang C; Wu P; Song GQ; Gao JN; Huang ZH; Xie T; Zhou JL
J Ethnopharmacol; 2021 Mar; 267():113467. PubMed ID: 33058923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
